Rates of self-directed perioperative cannabidiol use in patients undergoing total hip or knee arthroplasty. Academic Article uri icon

Overview

abstract

  • Aim: To evaluate the prevalence of self-directed cannabidiol (CBD) use in patients with end-stage degenerative hip and knee arthritis who underwent total hip arthroplasty and total knee arthroplasty. Materials & methods: Anonymous surveys for 109 patients were completed at 6 weeks follow-up after either total hip arthroplasty or total knee arthroplasty at a single tertiary care US orthopedic hospital. Results: Within the perioperative window encompassing both preoperative and postoperative periods, 22% (95% CI: 14-30%) of patients used CBD. Conclusion: There was no difference in pain satisfaction between patients who used CBD and patients who did not. Given high rates of self-directed perioperative CBD use and the mixed body of evidence, further research is needed to better understand whether CBD is safe and effective.

publication date

  • June 9, 2021

Research

keywords

  • Arthroplasty, Replacement, Hip
  • Arthroplasty, Replacement, Knee
  • Cannabidiol

Identity

Scopus Document Identifier

  • 85115657969

Digital Object Identifier (DOI)

  • 10.2217/pmt-2021-0018

PubMed ID

  • 34102871

Additional Document Info

volume

  • 11

issue

  • 6